martes, 25 de septiembre de 2018

New Images from NCI Visuals Online

New Images from NCI Visuals Online

National Cancer Institute



09/24/2018
NCI’s investments in cancer control, population health, and survivorship are aimed at reducing cancer risk, incidence, and mortality and on improving the quality of life of cancer survivors and the general population.
09/24/2018
This illustration shows how a swallowable balloon device helps detect Barrett esophagus, a condition that may confer a low risk of esophageal cancer.
09/24/2018
This schematic shows the steps for creating CAR T-cell therapy, a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells.
09/24/2018
There are hundreds of clinical trials underway studying CAR T-cell therapy, a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells.
09/24/2018
The total number of cancer deaths averted in men and women from 1991 to 2015 was 2,378,600.
09/24/2018
Information mapped in human tumor atlases will provide a comprehensive understanding of the ecosystem of tumors and show important transitions in cancer.
09/24/2018
This illustration shows the age-adjusted cancer mortality rate in rural and urban U.S. populations, stratified into six different population sizes.
09/24/2018
Among U.S. women age 40-74, 40% to 50% have dense breasts. Women with dense breasts have a higher risk of breast cancer.
09/24/2018
As has been true for many years, NCI continues to support a broad portfolio of research aimed at improving the early detection and diagnosis of cancer and its precursors.
09/24/2018
People with familial adenomatous polyposis (FAP) have a 100% lifetime risk of colon cancer.
09/24/2018
NCI’s mission is to lead, conduct, and support cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives.
09/24/2018
The NCI Method to Extend Research in Time (MERIT) (R37) Award provides longer term grant support to early stage investigators. This graph shows that R01 awards provide 5 years of funding versus R37 awards, which provide 7 years of funding.
09/24/2018
NCI Cancer Centers diagnose 250,000 cancer cases each year.
09/24/2018
Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.
09/24/2018
Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.
09/24/2018
Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.
09/24/2018
Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.
09/24/2018
To advance precision medicine in cancer care, a National Cancer Data Ecosysem is necessary.
09/24/2018
This graph shows the number of new U.S. cancer cases and deaths each year per 100,000 persons by race/ethnicity and sex.
09/24/2018
Dr. Ned Sharpless, director of the National Cancer Institute, with Mike, a patient he treated for acute leukemia. Cancer patients like Mike are NCI's true partners in cancer research.

No hay comentarios:

Publicar un comentario